Cell Reports Medicine

Cell Reports Medicine 由 Elsevier 出版，属中科院医学大类（2025 升级版1区，Top 期刊）。按 OpenAlex 近年发文统计，该刊主要发表 Cancer Immunotherapy and Biomarkers、Immune Cell Function and Interaction、CAR-T cell therapy research 等主题的论文，这 3 个主题约占 26%，主导子领域为 Immunology。（根据 OpenAlex 主题统计与中科院分区数据生成）

Cell Reports Medicine is a premium open-access journal from Cell Press publishing cutting-edge research in translational and clinical biomedical sciences that inform and influence human health and medicine.The content published in Cell Reports Medicine reaches a broad range of scientists and clinicians across the spectrum of medical disciplines, ensuring that your work will be both visible and accessible. The journal publishes original research that ranges from exciting concepts in human biology, health, and disease to all phases of clinical work. We encourage submissions featuring innovative ideas that open up new directions in clinical research and practice, as well as studies that provide critical information that enriches our understanding of current standards of care in diagnosis, treatment, and prognosis. This includes, but is not limited to, translational studies, clinical trials in all areas of medicine including long-term trial follow-ups as well as work in genomics, biomarker discovery, and developments in technology that contribute to diagnostics, treatment, and healthcare. Studies based on vertebrate model organisms also fall within the scope of the journal, provided that the results are directly relevant to human health and disease.Like our sister journal Cell Reports, we will consider impactful, single-point papers called reports, in addition to longer articles. Large datasets, techniques, and tools for the community can also be considered under the article format. We will also publish reviews covering recent literature in emerging and active fields.The professional in-house scientific editors at Cell Reports Medicine work closely with authors, reviewers, and the journal's editorial board to ensure exemplary editorial process, fair and robust peer review, and rapid dissemination and communication of your research.

摘自期刊官网 Aims & Scope

研究方向（LetPub）：Biochemistry, Genetics and Molecular Biology-Biochemistry, Genetics and Molecular Biology (all)

中科院期刊分区表

数据库收录

SCIEScopusDOAJLetPub

国际期刊预警名单：各版本均未列入LetPub

不同版本、大类与小类分别展示，不将不同评价口径合并为一个分区值；投稿与考核前请确认所在机构采用的版本。

影响力指标

影响因子

13.97LetPub · 2026-09-13

影响因子（出版商公布）

14出版商官网 · 2026-10-01

CiteScore 2026-06

15.9LetPub · 2026-09-13

CiteScore（出版商公布）

15.9出版商官网 · 2026-10-01

SJR 2026-06

4.93LetPub · 2026-09-13

SNIP 2026-06

2.32LetPub · 2026-09-13

h-index

105OpenAlex · 2026-10-01

i10-index

1,252OpenAlex · 2026-10-01

两年平均被引

12.17OpenAlex · 2026-10-01

自引率

0.7%LetPub · 2026-09-13

Gold OA 文章占比

99.73%LetPub · 2026-09-13

发文规模

年文章数

417LetPub · 2026-09-13

不同来源的统计口径与观测时间不同，页面保留各来源原值；“出版商公布”为期刊官网自述数据。

其他来源

平均审稿速度（社区反馈）

期刊官网数据：平均Time to desk decision: 6.6 days; Publication time: 3.31 weeks网友分享经验：17 WeeksLetPub · 2026-09-13

平均录用比例（社区反馈）

32.34%LetPub · 2026-09-13

投稿到首次决定

6 天出版商官网 · 2026-10-01

外审后首次决定

43 天出版商官网 · 2026-10-01

投稿到接收

205 天出版商官网 · 2026-10-01

接收到发表

27 天出版商官网 · 2026-10-01

投稿到发表（期刊自报）

约 36 周DOAJ · 2026-10-11

评审方式

单盲同行评审DOAJ

社区反馈来自投稿者样本，置信度 0.5，不代表期刊承诺；“出版商公布”的时间节点定义以官网为准。

• APC 费用说明 ↗DOAJ
• 费用减免政策 ↗DOAJ
• 开放获取声明 ↗DOAJ
• 许可与版权 ↗DOAJ

费用以期刊官网为准；不同来源的观测时间可能不同，页面保留各来源原值，不做平均。

摘录来自期刊官网页面，仅保留原文片段；“模型摘要”由 Workers AI 生成并经原文校验，以官网为准。

出版商

Elsevier

出版国家或地区

United States

出版语言

English

出版周期

Monthly

创刊年份

2020

ISSN

2666-3791

官方链接

• 期刊主页 ↗DOAJ
• 投稿系统 ↗出版商官网
• 作者指南 ↗DOAJ
• Aims & Scope ↗DOAJ
• 专刊 / 特刊征稿 ↗出版商官网
• APC 费用说明 ↗DOAJ
• 费用减免政策 ↗DOAJ
• 开放获取声明 ↗DOAJ
• 许可与版权 ↗DOAJ
• 评审流程 ↗DOAJ
• 编委会 ↗DOAJ
• 查重政策 ↗DOAJ